CART-19 for Multiple Myeloma
NCT02135406
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
13
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
BIOLOGICAL:
CART-19 T cells
Sponsor
University of Pennsylvania